newsfilter
← Latest News
Business Wire·

Xeris Announces Details for Analyst & Investor Day

Hybrid Event Offering In-Person or Virtual Attendance on Tuesday, June 3, 2025 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by